Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS

NCT01272882 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2017-05-25

Study results available
· View outcomes & findings →

Summary

Electrical impedance tomography (EIT) monitoring has been researched as a method to determine the spatial impedance distribution in a body cross section, but has yet to become an established clinical tool. EIT monitoring gives a dynamic, breath-to-breath measurement of both global and regional ventilation. Recently, there has been evidence that EIT monitoring has great potential to become a non-invasive bedside tool for assessment of regional lung ventilation without documented hazards. Potential applications include any adult patients in acute respiratory failure. Data collected from this research may contribute to improved patient safety outcomes.

PURPOSE:

The purpose of this pilot study is to examine the feasibility of using the EIT monitor in intensive care unit (ICU) setting on patients with acute respiratory failure and to compare the EIT monitor data to standard of care patient assessments. It is hypothesized that the EIT monitor, when applied to adults in acute respiratory failure, will correlate with conventional standard of care assessments for these patients.

Conditions

  • Acute Lung Injury (ALI)
  • ARDS

Interventions

DEVICE

Electrical Impedance Tomography monitoring

Chest belt with 16 electrodes connected to the EIT device

Sponsors & Collaborators

  • Christiana Care Health Services

    lead OTHER

Principal Investigators

  • John S Emberger, BS · Christiana Care Health Services

  • Vinay Maheshwari, MD · Christiana Care Health Services

  • Joel M Brown, BS · Christiana Care Health Services

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01272882 on ClinicalTrials.gov